Suturing peripheral nerve transections is the predominant therapeutic strategy for nerve repair. However, the use of sutures lead to scar tissue formation, hinder nerve regeneration, and prevent functional recovery. Fibrin-based adhesives have been widely used for nerve reconstruction, but their limited adhesive and mechanical strength, and inability to promote nerve regeneration hampers their utility as a stand-alone intervention. To overcome these challenges, we engineered composite hydrogels that are neuro-supportive and possess strong tissue adhesion. These composites were synthesized by photocrosslinking two naturally derived polymers, gelatin-methacryloyl (GelMA) and methacryloyl-substituted tropoelastin (MeTro). The materials exhibited tunable mechanical properties by varying the GelMA/MeTro ratio. In addition, GelMA/MeTro hydrogels exhibited 15-fold higher adhesive strength to nerve tissue ex vivo compared to fibrin controls. Furthermore, the composites were shown to support Schwann cell viability and proliferation, as well as neurite extension and glial cell participation in vitro, which are essential cellular components for nerve regeneration. Lastly, subcutaneously implanted GelMA/MeTro hydrogels exhibited slower degradation in vivo when compared with pure GelMA, indicating its potential to support the growth of slowly regenerating nerves. Thus, GelMA/MeTro composites may be used as clinically relevant biomaterials to regenerate nerves and reduce the need for microsurgical suturing during nerve reconstruction.
Introduction
Peripheral nerve injury (PNI) often leads to partial or complete loss of sensation, chronic pain, apraxia, and even permanent disability (1) . Due to the slow rate and limited ability of the peripheral nervous system (PNS) to regenerate (2) , surgical intervention is often required for function recovery. Regardless of the type of surgical intervention for PNI (e.g., anastomosis ( Figure 1A ) or grafting ( Figure 1B) ), standard therapies most often involve the use of nylon or polypropylene sutures to mechanically stabilize and reconstruct nerves (3, 4) . However, the use of nylon or polypropylene sutures for nerve anastomosis further damages the injured tissue resulting in increased tension, inflammation, and the development of a foreign body response (FBR) (3) (4) (5) . In particular, excess tension in neural tissues has been associated with reduced angiogenesis, which is essential for the promotion of tissue remodeling and axonal regeneration (6) .
Several sutureless interventions have been proposed, including tissue laser welding (LTW) (7, 8) , photochemical bonding (PTB) (9, 10) , as well as the use of bioadhesives (11) (12) (13) (14) .
While promising, these strategies have a number of limitations for PNS repair. LTW can thermally induce damage to proximal nerve fibers, slowing functional recovery. Further, LTW often requires suturing to mechanically stabilize the nerve. On the other hand, PTB can only be utilized for non-gap and critical size injuries (12) . Neural glues are an attractive approach to overcome these limitations, but current compositions and formulations have not met the mechanical and adhesive properties required for sutureless repair.
Specifically, fibrin-based glues have low stiffness and adhesion and high risk of infection (15, 16) , cyanoacrylate glues lack biocompatibility and often elicit a FBR (17, 18) , and polyethylene glycol (PEG)-based tissue bonding degrades too slowly, persisting for years following implantation (12, 13) . Therefore, an elastic and biocompatible biomaterial with appropriate tissue adhesion and stiffness that can also support neurite outgrowth may be advantageous to overcome the limitations of current sutureless repair strategies.
Herein, we developed a photocrosslinkable composite of gelatin-methacryloyl (GelMA) and methacryloyl-substituted tropoelastin (MeTro) hydrogels ( Figure 1C This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
two biopolymers with distinctive biophysical and biochemical characteristics enabled the engineering of hydrogels with a wide spectrum of physicochemical properties. We evaluated the physical properties of the engineered hydrogels, including porosity, stiffness, elasticity, swellability, and in vitro and in vivo degradation rates. Additionally, we examined the efficacy of the engineered GelMA/MeTro composite to act as an adhesive for nerve anastomosis ex vivo. We also investigated the ability of this material to support the viability and proliferation of Schwann cells (SCs), and extension of PNS neurons encapsulated within the composite hydrogels. Lastly, we evaluated the biodegradability and immunogenicity of the engineered hydrogels when implanted subcutaneously in vivo.
We hypothesize that the engineered GelMA/MeTro hydrogel may be used as a multifunctional adhesive with regenerative capabilities for nerve repair and anastomosis.
Materials and Methods

GelMA and MeTro synthesis.
GelMA was synthesized by adding 8% (v/v) methacrylic anhydride (MA, Sigma) to a 10% (w/v) fish gelatin solution in Dulbecco's phosphate buffered saline (DPBS, Sigma), as previously described (19) . This reaction was carried out at 60 ºC for 2 h, and stopped by adding a 3x dilution of warm (60 ºC) DPBS. The mixture was dialyzed (Spectra/Por 12-14kD, Fisher Scientific) using distilled water for 1 week at 60 ºC, frozen at -80 ºC, lyophilized, and stored at room temperature for use on demand.
Similarly, a 10% (w/v) tropoelastin isoform (SHELΔ26A, synthetic human elastin without amino acid residues 27-724 of GenBank entry AAC98394) solution was mixed with 8% (v/v) MA to form MeTro, as previously reported (20) . The reaction was carried out for 12 h at 4 ºC and then stopped by adding a 3x dilution of cold (4 ºC) DPBS. The diluted solution was then dialyzed (Slide-A-Lyzer Dialysis Cassette, 3,500 MWCO) for 48 h in distilled water at 4 ºC. The resulting MeTro was frozen at -80 ºC, lyophilized, and stored at room temperature for on demand use. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Hydrogel fabrication.
Composite hydrogels were synthesized of varying ratios of GelMA and MeTro and different total polymer concentrations. Hydrogel precursor solution was prepared in distilled water with 0.5% (w/v) 2-hydroxy-1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-propanone (Irgacure 2959, CIBA Chemicals). To ensure a homogenous precursor solution, the mixture was placed on ice for 15 min until both polymers dissolved completely. (21) . Where PA b is equal to the peak area before crosslinking and PA a is the peak area after crosslinking. Peak areas were measured using ACD/Spectrus NMR to integrate the area of the curve with respect to phenolic conjugated peaks at δ = 6.5-7.5 ppm.
Mechanical characterization.
Compressive and tensile properties of hydrogel formulations were measured at a 1 mm/min strain rate using a universal load frame (Instron Model 5542 This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
the maximum stress and strain/extensibility at tensile failure, respectively. We investigated the effect of the GelMA/MeTro ratio, final polymer concentration, and light exposure time on the mechanical properties of the hydrogels using at least three independent samples for each set of conditions. The results are shown as the average ± standard deviation.
Scanning electron microscopy (SEM) analysis.
All samples were lyophilized, mounted on aluminum pin stubs, and sputter coated with a 6 nm gold/palladium (Au/Pd) layer. SEM images were acquired by using a Hitachi S-4800 SEM at 15 kV and an 8 mm working distance. GelMA/MeTro hydrogels were all processed in the same conditions, based on a method reported previously in the literature (22).
Swelling ratio and in vitro degradation characterization.
Hydrogels samples were frozen at -80 °C, lyophilized, and weighed to determine their dry weights. To measure swelling hydrogels were soaked in DPBS at 37 °C for different time points (1, 2, 4, 8, 12 , 24 h) and re-weighed. Swelling ratios were calculated as the change between the wet and dry weights over the dry weight. For the in vitro degradation study, each sample was kept in 1 ml of 5% (v/v) fetal bovine serum (FBS, Corning) in DPBS at 37 ºC for 1, 7, or 14 days. At these established time points, the solutions were removed and the samples were frozen, lyophilized, and weighed again. The percentage of degradation was calculated as a ratio of the final and initial dry weights of the hydrogels.
Nerve anastomosis.
Sciatic nerve explants (~18 mm) proximal of the bifurcation at the knee and distal from the spinal column, were dissected from the legs of adult rats ( This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
of SCs was evaluated using the PrestoBlue assay (Life Technologies) and a Synergy HT fluorescence plate reader (BioTek).
3D encapsulation and culture of whole dorsal root ganglia (DRG).
DRGs, from the thoracic and lumbar regions of the spinal column, were isolated from p2
Sprague-Dawley neonatal rats per established protocols (23, 28, 29) . DRGs were collected and randomized across three animals from two separate litters (total = six p2 pups) and were encapsulated in hydrogels in a similar manner to SCs (see section 2.8). A single whole DRG was suspended in ~10 µL of a 50/50 GelMA/MeTro (10% (w/v) final polymer concentration) precursor solution and placed between a 300 µm-tall spacer. Samples were photocrosslinked and incubated in standard culture conditions for 7 days. DRG maintenance medium (Neurobasal medium (Gibco) supplemented with 1x B27 (Gibco), 2 mM L-glut, 50 U mL −1 P/S, and 25 ng mL -1 nerve growth factor (Gibco)) was changed every other day. DRG outgrowth was quantified by the total outgrowth area in MATLAB as previously reported (30).
Immunocytochemistry (Actin/DAPI/S100/β3T).
Cell-laden hydrogels were fixed in 4% paraformaldehyde for 30 min, permeabilized with 0.1% X-100 Triton (Sigma) for 30 min at room temperature, and blocked overnight at 4 ºC with 5% goat serum (Sigma). After blocking, rabbit anti S-100 (DAKO, Z0311) and/or mouse anti β-3 tubulin (Invitrogen, 480011) (1:400 in 5% goat serum) were added overnight at 4 ºC. After primary antibody incubation, cell-laden hydrogels were washed with DPBS and anti-rabbit and/or anti-mouse secondary antibodies (1:200 and phalloidin (Life Technologies, A22287) 1:400 in goat serum) were added overnight at 4 ºC. Samples were washed with DPBS, mounted on cover slides with ProLong® Gold Antifade with 4',6-diamidino-2-phenylindole (DAPI), and imaged using an inverted fluorescence microscope (Zeiss Axio Observer Z1).
In vivo degradation and biocompatibility.
Male Wistar rats (200 -250 grams) (Charles River) were anesthetized using 1 -2.5%
isoflurane, and lyophilized hydrogel samples (50/50 GelMA/MeTro at 10% (w/v) total This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
polymer concentration), prepared in PDMS molds (cylinders 4.92 mm diameter, 3.85 mm height), were implanted subcutaneously, as previously described (31-33). On days 4, 14, 28, and 56 post implantation, rats were euthanized and the hydrogels, along with the adjacent tissue, were explanted. Surrounding tissue was carefully removed for samples used to evaluate the degradation rate in vivo. These explants were then lyophilized overnight so that the final dry weight could be measured. Degradation ratios were reported as final dry weight/initial dry weight for each post implantation time point.
Following explantation, samples were fixed for 4 h in 4% paraformaldehyde in DPBS, incubated overnight at 4 ºC in 30% sucrose in DPBS, embedded in OCT compound, and flash frozen in dry ice. Fifteen-µm cryo-sections were obtained using a Leica Biosystems CM3050S Research Cryostat. Immunohistological staining was performed as previously reported (34) . Samples were stained for lymphocytes (1:100 Anti-CD3 [SP7], ab16669, Abcam) and macrophages (1 μg/mL anti-CD68, ab125212, Abcam), detected using an Alexa
Fluor 546-conjugated secondary antibody (Invitrogen, A11034) and counterstained with DAPI (Invitrogen). Cryo-sections were attached to positively charged slides and mounted using DPX mounting medium (Sigma) and images were acquired using an AxioObserver Z1 inverted microscope. Slides were processed for H&E staining per instructions from the manufacturer.
Statistical analysis.
Data were compared using one-way ANOVA test in GraphPad Prism software. Error bars represent the mean ± standard deviation of measurements (*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001). For mechanical characterization, swelling ratio, in vitro and in vivo degradation, SC metabolic activity, SC viability (4 images/gel), DRG outgrowth, and histological staining (7 slides/gel) a minimum of three independently prepared samples were used to determine the average and standard deviation. A total of 6 nerves were used for each nerve anastomosis condition.
Animal use statement.
All animals were treated following Northeastern University's Institutional Animal Care and Use Committee approved protocols. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Results
Synthesis and Fabrication of GelMA/MeTro Hydrogels
To engineer a multifunctional material for the treatment of PNI, recombinant human tropoelastin and gelatin were methacrylated to form the photocrosslinkable biopolymers GelMA (19) and MeTro (20) . 1 H NMR spectra were taken from dissolved GelMA ( Figure 1D) and MeTro ( Figure 1E ) in D 2 O, and partially dissolved GelMA/MeTro composite in DMSOd6 ( Figure 1F ) to quantify the degree of crosslinking (35) . These results indicated that the methacrylate groups present in GelMA and MeTro were involved in the formation of the composite hydrogel. In these spectra, the methacrylate groups (-C=CH 2 ) appeared as characteristic peaks at δ=5.3 ppm (peak 1, 3, 5) and δ=5.7 ppm (peak 2, 4, 6). The disappearance of peaks 5 and 6, shown in the GelMA/MeTro spectra and normalized to phenolic conjugated peaks (δ = 6.5-7.5 ppm), indicated that the degree of crosslinking was approximately 73.3% following exposure to light.
Mechanical Characterization of GelMA/MeTro Hydrogel
The mechanical properties of GelMA/MeTro hydrogels were tuned by varying the ratio of GelMA to MeTro (Figure 2A-F) , the total polymer concentration ( Figure S1A-B) , and the crosslinking time (Figure S1C-D) . Tensile tests showed statistically significant differences in the mechanical properties between the composites, and pure GelMA and MeTro hydrogels (Figure 2A-C) . Specifically, the tensile modulus, strain at failure, and ultimate stress of the composites decrease by increasing the GelMA/MeTro ratio (Figure 2A-C) .
Based on the cyclic compression test, it was found that composites had compressive moduli greater than those of pure GelMA or MeTro hydrogels (Figure 2D-E) . Results also demonstrated that the compressive moduli of 50/50 GelMA/MeTro hydrogels increased concomitantly by increasing the total polymer concentration (Figure S1A-B ). An increase in total polymer concentration of GelMA or MeTro hydrogels may result in a higher degree of crosslinking, and thus, increased modulus (19, 20) . In addition, the compressive moduli of the composites increased with increasing light exposure time (Figure S1C-D) . This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Structural Characteristics, Swelling Ratios, and In Vitro Degradation of GelMA/MeTro Hydrogels
The microstructure of hydrogels has been shown to influence cell infiltration and tissue integration (36) . Analysis of hydrogel structure via SEM demonstrated the influence of varying ratios of GelMA and MeTro on the composite microarchitecture ( Figure S2 ). While observable differences in hydrogel porosity and structure were apparent among different formulations, this could be due in part to the lyophilization of the samples prior to SEM analysis (36).
Swellability is an important factor for material design, as increased permeability can improve the diffusion of nutrients, oxygen, and metabolic waste (37) . Conversely, materials that exhibit limited swelling may be favorable for implantation, as materials with high levels of swelling may increase interstitial pressure at the injury site (38, 39) .
Therefore, the swellability of GelMA/MeTro hydrogels was evaluated in a model physiological fluid. The swelling ratio of pure GelMA hydrogels was nearly five times that of MeTro after 24 h of incubation in DPBS, while the composites exhibited swelling ratios between that of each pure species ( Figure 2G ). In addition, the swelling ratios for all tested GelMA/MeTro composites decreased by increasing the total polymer concentrations ( Figure S3A) , which was consistent with previously reported trends for pure GelMA hydrogels (40) . Similarly, increasing the time of crosslinking from 30 to 60 s also resulted in a decrease in swelling ratio, which was approximately halved for all measured time points, likely due to increased crosslinking ( Figure S3B ) (40, 41) .
Swellability may also influence the rate of degradation for hydrogels in vitro (42) .
Increasing the concentration of GelMA in the composites led to an increase in the degradation rate in DPBS supplemented with 5% FBS over 14 days ( Figure 2H) . The degradation ratio of the composites increased from 3.85 ± 3.55% for pure MeTro to 18.73 ± 3.88% for pure GelMA after 24 h ( Figure 2H ). This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Adhesive Strength of GelMA/MeTro Composites for Nerve Anastomosis
To recapitulate the ideal surgical intervention strategy currently utilized with fibrin and sutures (43), the severed proximal and distal nerve stumps of an adult rat sciatic nerves were connected end-to-end ex vivo using GelMA/MeTro and a commercially available fibrin based glue, Evicel Figure 3B ). In addition, the adhesive strength of GelMA/MeTro composites was 2-fold higher than a previously proposed photocrosslinkable chitosan hydrogel for nerve repair (71.3 ± 23.4 kPa) (44) . The strain at failure for ex vivo anastomosis was 14 ± 3% ( Figure 3C ), which was higher than the value reported for the permanent nerve dysfunction (~10% strain) (45, 46) . Lastly, histological assessment of the interface between the composites and the native nerve tissue showed penetration and entanglement of GelMA/MeTro adhesives at the interface of an anastomosed sciatic nerve ( Figure 3D) . We observe similar behavior in our previous work where MeTro was used as lung and artery adhesive (47).
3D Encapsulation of SCs in GelMA/MeTro Composite Hydrogels
SCs play a key role in peripheral nerve regeneration, viability, proliferation, metabolic activity, and morphology in vitro (48) (49) (50) (51) . To examine the potential for GelMA/MeTro hydrogels to support peripheral glia, SCs from the sciatic nerve were used as a model cell to assess the cellular compatibility of the composite. SC viability increased from 58.85 ± 3.79% on day 1, to >85% by day 5 post encapsulation ( Figure 4A-B) , which is typical of SC encapsulation in collagen-based hydrogels (52, 53) . SCs exhibited round morphologies with little spreading at day 1 post encapsulation, followed by proliferation and spreading within the matrix at day 5 ( Figure 4C ). Cell proliferation was quantified by tracking the number of DAPI-stained cell nuclei over time ( Figure 4D ). The expression of S100, a SC specific marker, also confirmed that the SC phenotype was maintained in our composites ( Figure   4E ) (54) . A PrestoBlue assay demonstrated that the metabolic activity of the encapsulated This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
SCs increased consistently throughout the 5 days of culture ( Figure 4F ). However, both the metabolic activity and number of cells remained constant from day1 to day 3.
DRG Outgrowth within GelMA/MeTro Composite Hydrogel
To evaluate the ability of composite hydrogels to support neurite extension in 3D, the morphology of whole DRGs encapsulated within GelMA, MeTro, and 50/50 GelMA/MeTro (10% (w/v) total polymer concentration) composites was characterized. DRGs were utilized to represent an heterogenous population of PNS neurons and glia (SCs). As shown in Figure 5A , robust neurite outgrowth was observed within pure GelMA hydrogels and GelMA/MeTro composites. In contrast, neurite outgrowth was hindered in pure MeTro hydrogels, likely due to the higher stiffness of MeTro (20) . Despite the difference in mechanical stiffness, the quantification of neurite outgrowth (30) revealed no statically significant differences between GelMA and 50/50 GelMA/MeTro hydrogels ( Figure 5B) .
Further, immunofluorescent staining of outgrowth showed that the SCs endogenously found within whole DRGs, were able to migrate from the encapsulated DRG within GelMA/MeTro hydrogels ( Figure 5C ).
Subcutaneous Implantation and In Vivo Degradation of GelMA/MeTro Hydrogel
A murine subcutaneous implantation model was used to evaluate degradation of GelMA/MeTro in vivo. Explanted GelMA/MeTro hydrogels decreased consistently until day 28, followed by complete biodegradation at day 56 ( Figure 6A-B) . The discrepancies between the estimations by weight and by volume are likely due to progressive tissue ingrowth within the composites (Figure 6C-E) . As expected, the in vivo degradation rate of subcutaneously implanted composites was slower than GelMA (~one week for GelMA) (22) , and faster than MeTro hydrogels (>4 weeks for MeTro) (34) .
As shown in Figure 6C -E, histological examination of explanted samples at days 4 to 28 post implantation revealed minimal progressive tissue ingrowth. As the material degraded, a high density of cell infiltration is observed throughout the entire sample on day 28 shown to elicit minimal immunogenicity, and to be completely biodegraded at day 56 post implantation, which is a clinically relevant time frame for PNI recovery.
Discussion
Photocrosslinkable materials may constitute a rapid strategy to reconnect nerve ends together during primary traumatic care, as opposed to secondary or revision surgical interventions (44) . The bonding strength of photocrosslinked adhesives to tissues may increase in vivo by covalent bonds generated by free radicals during the curing process This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
light has no harmful effects for the encapsulated cells (61, 62) . Here, SCs encapsulated within UV crosslinked GelMA/MeTro composite proliferated and recovered, which indicates the potential of the hydrogels to serve as a biomaterial-based vehicle for SC delivery.
As an initial proof-of-principle test, an ex vivo evaluation of nerve anastomosis of murine sciatic nerves highlighted the potential of this material for sutureless repair (Figure 3) .
Here, the composite precursor is likely to form interactions with the individual fascicles within the nerve, increasing the total surface area in contact with the tissue after crosslinking, and thus, the overall shear forces during extension (63) . This hypothesis was supported by the gradual failure of the adhesive in the stress-strain curves ( Figure 3C ), similar to that observed for intact nerves (64) . In addition, GelMA/MeTro adhesives may be capable of withstanding the physiological levels of strain (~10%) for immobilized extremities following PNI (45, 46) , which is common for the treatment of musculoskeletal injuries (65, 66) . The rapid solidification of our material may enable nerve repair to be carried out at the initial point of care, reducing the number of surgical revisions. To further improve the mechanical stability of GelMA/MeTro as a neural adhesive as well as reducing the risk of neuroma formation, our material may be used in combination with neural wraps and conduits to provide structural cues for axonal regeneration (67) . In this case, a combinatorial design using a pure MeTro hydrogel as a neural wrap may reduce the risk of neuromas by preventing neurite extension and isolating the injury site from surrounding tissue.
Additionally, this GelMA/MeTro composite system may be well suited for glial support cell delivery as the cell-laden hydrogel precursor solutions possess a low viscosity (68), ensuring low shear stress during injection and homogenous distribution of SC payload (69) .
The PNS has a remarkable regenerative potential when compared to the central nervous system (2). However, this regenerative ability is insufficient for large gap injuries (>4 cm), since the axonal growth rate has been shown to only be ~1 mm/day (70 This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
N-cadherin) (71), secrete neurotropic factors (72) , and generate ECM proteins, that promote neurite extension (73) .
Autografts remain the preferred treatment as they provide not only a structured conduit for axonal guidance, but possess a homogenous distribution of autologous SCs. Thus, SC inclusion must be taken into consideration for the design of synthetic alternatives as the inclusion of exogenous SCs within these conduits was shown to be a promising strategy to increase the rate of nerve regeneration (52, 67, 74) . Although the tensile moduli of the engineered composites herein were below those of native neural tissues (~22.7 MPa) (44), GelMA/MeTro hydrogels provided a neuro-supportive environment, which may enhance regeneration following an injury. Here, 3D encapsulated SCs in GelMA/MeTro hydrogels displayed a characteristic elongated morphology (Figure 4 ) after an initial quiescent period following encapsulation, an improvement over alginate-based hydrogel, which was previously used for 3D encapsulation and delivery of SCs (75, 76) . Encapsulated SCs exhibited round morphologies in alginate due to an absence of cell adhesion domains, ultimately leading to atypical behavior. Both gelatin and tropoelastin are likely to promote SC adhesion because of cell-binding domains within their structure (77) . GelMA hydrogels have been shown to support the growth and proliferation of 3D encapsulated cells, due to the presence of Arg-Gly-Asp (RGD) domains (19) . In addition, SCs have also been shown to express αvβ3 integrins, which function as cell-binding cites within tropoelastin (78, 79) .
While GelMA was less stiff than MeTro, pure GelMA hydrogels contain several matrix metalloproteinase (MMP)-sensitive degradation sequences (80) , exposing them to more rapid degradation, reduced tissue integration, and change in bulk mechanical properties in vivo (22) . These dynamic properties following implantation are bolstered by SC overexpression of MMPs to remove cellular debris following PNI (81, 82) , which may further expedite degradation. A slower degradation rate achieved with higher loading fractions of MeTro may provide a suitable isolated microenvironment to protect the injury site from fibrosis and inflammation during regeneration (13, 83) . Further, in our recent work, we have shown that MeTro hydrogels can adhere to the tissue due to physical interaction and interlocking, as well as charge interactions (positively charged tropoelastin and negatively charged glycosaminoglycans on the ECM) (47) . In addition, MeTro coacervates at body This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
temperature (20) , making the precursor solution hydrophobic following injection; therefore, the material will stay confined to the site of application (47) . All these unique properties of MeTro, in combination with the high biocompatibility of GelMA could support neurite extension from encapsulated DRGs in vitro ( Figure 5 ) and may ultimately enhance the rate of peripheral nerve regeneration in vivo.
Successful repair in large-gap injuries with off-the-shelf solutions require both guidance cues and SC participation to support outgrowing axons traversing the coaptation site (84) . 
Conclusion
In this study, we engineered a highly biocompatible GelMA/MeTro hydrogel adhesive with 
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Representative SEM images from the cross-sections of MeTro, 50/50 GelMA/MeTro, and
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